Figure S1 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
<p>Supplementary Figure 1: T cell responses in A2.DR1 and DR4 mice after peptide vaccination with potential shared neoepitopes. A. Predicted binding affinity for selected amino acid alterations for HLA-A*0201 determined by NetMHC 4.0. B, C. Quantification of IFN-γ ELISpot using cells isolated...
שמור ב:
| מחבר ראשי: | Michael Kilian (16697663) (author) |
|---|---|
| מחברים אחרים: | Mirco Friedrich (3721555) (author), Khwab Sanghvi (16697666) (author), Edward Green (3822586) (author), Stefan Pusch (14934437) (author), Daisuke Kawauchi (15115187) (author), Martin Löwer (133159) (author), Jana K. Sonner (16697669) (author), Christopher Krämer (16697672) (author), Julia Zaman (16697675) (author), Stefanie Jung (554730) (author), Michael O. Breckwoldt (16697678) (author), Gerald Willimsky (16697681) (author), Stefan B. Eichmüller (16697684) (author), Andreas von Deimling (15037904) (author), Wolfgang Wick (15018168) (author), Felix Sahm (15097382) (author), Michael Platten (15018165) (author), Lukas Bunse (16697687) (author) |
| יצא לאור: |
2025
|
| נושאים: | |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
פריטים דומים
-
Figure S2 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
מאת: Michael Kilian (16697663)
יצא לאור: (2025) -
Figure S3 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
מאת: Michael Kilian (16697663)
יצא לאור: (2025) -
Supplementary Table S1 from Neoantigen Targetability in Progressive Advanced Melanoma
מאת: Jitske van den Bulk (17142147)
יצא לאור: (2025) -
Supplementary Table S2 from Neoantigen Targetability in Progressive Advanced Melanoma
מאת: Jitske van den Bulk (17142147)
יצא לאור: (2025) -
Supplementary Table S3 from Neoantigen Targetability in Progressive Advanced Melanoma
מאת: Jitske van den Bulk (17142147)
יצא לאור: (2025)